THC Farmaceuticals Inc (CBDG)
0.043
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
THC Farmaceuticals Shareholders Equity (Quarterly): 1.014M for June 30, 2015
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2018 | 0.7837M |
March 31, 2018 | 0.7893M |
June 30, 2015 | 1.014M |
March 31, 2015 | 0.0161M |
December 31, 2014 | 0.0338M |
September 30, 2014 | -0.048M |
June 30, 2014 | -0.0394M |
March 31, 2014 | -0.0351M |
December 31, 2013 | -0.0315M |
September 30, 2013 | -0.0173M |
Date | Value |
---|---|
June 30, 2013 | -0.013M |
March 31, 2013 | -0.0077M |
December 31, 2012 | -0.0051M |
September 30, 2012 | 0.0065M |
June 30, 2012 | 0.021M |
March 31, 2012 | 0.0224M |
December 31, 2011 | 0.0329M |
September 30, 2011 | 0.0462M |
June 30, 2011 | 0.0523M |
September 30, 2010 | 0.0746M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
CEL-SCI Corp | 12.65M |
AIM ImmunoTech Inc | 10.23M |
IGC Pharma Inc | 9.053M |
NovaBay Pharmaceuticals Inc | 3.314M |
Protalix BioTherapeutics Inc | 33.57M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.715M |
Total Liabilities (Quarterly) | 0.701M |